Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007, Article ID 47523, 7 pages
http://dx.doi.org/10.1155/2007/47523
Research Article

Calotropis procera Latex Extract Affords Protection against Inflammation and Oxidative Stress in Freund's Complete Adjuvant-Induced Monoarthritis in Rats

Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India

Received 1 December 2006; Revised 12 February 2007; Accepted 12 February 2007

Copyright © 2007 Vijay L. Kumar and Sanjeev Roy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. D. Brandt, “Osteoarthritis,” in Harrison's Principles of Internal Medicine, D. L. Kasper, E. Braunwald, A. S. Fauci, S. L. Hauser, D. L. Longo, and J. L. Jameson, Eds., vol. 2, pp. 2036–2045, McGraw-Hill, New York, NY, USA, 16th edition, 2005.
  2. J. A. Markenson, “Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 21, no. 2 supplement 1, pp. 4–12, 1991. View at Publisher · View at Google Scholar
  3. P. H. Wooley, “Animal models of rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 3, no. 3, pp. 407–420, 1991. View at Publisher · View at Google Scholar
  4. C. M. Pearson, “Development of arthritis, periarthritis and periostitis in rats given adjuvants,” Proceedings of the Society for Experimental Biology and Medicine, vol. 91, no. 1, pp. 95–101, 1956.
  5. P. A. Nigrovic and D. M. Lee, “Mast cells in inflammatory arthritis,” Arthritis Research and Therapy, vol. 7, no. 1, pp. 1–11, 2005. View at Publisher · View at Google Scholar · View at PubMed
  6. K.-I. Yamada, T. Nakamura, and H. Utsumi, “Enhanced intraarticular free radical reactions in adjuvant arthritis rats,” Free Radical Research, vol. 40, no. 5, pp. 455–460, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. S. M. Wahl, “The role of lymphokines and monokines in fibrosis,” Annals of the New York Academy of Sciences, vol. 460, no. 1, pp. 224–231, 1985. View at Publisher · View at Google Scholar
  8. Z. Szekanecz, M. M. Halloran, and M. V. Volin et al., “Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis,” Arthritis and Rheumatism, vol. 43, no. 6, pp. 1266–1277, 2000. View at Publisher · View at Google Scholar
  9. S. B. Abramson, M. Attur, A. R. Amin, and R. Clancy, “Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis,” Current Rheumatology Reports, vol. 3, no. 6, pp. 535–541, 2001.
  10. P. H. J. Remans, M. van Oosterhout, and T. J. M. Smeets et al., “Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 52, no. 7, pp. 2003–2009, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. W. D. Blackburn Jr., “Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities,” The American Journal of Medicine, vol. 100, no. 2A, pp. 24S–30S, 1996. View at Publisher · View at Google Scholar
  12. J. K. Rao, K. Mihaliak, K. Kroenke, J. Bradley, W. M. Tierney, and M. Weinberger, “Use of complementary therapies for arthritis among patients of rheumatologists,” Annals of Internal Medicine, vol. 131, no. 6, pp. 409–416, 1999.
  13. V. L. Kumar and S. Arya, “Medicinal uses and pharmacological properties of Calotropis procera,” in Recent Progress in Medicinal Plants, J. N. Govil, Ed., vol. 11, pp. 373–388, Studium Press, Houston, Tex, USA, 2006.
  14. V. L. Kumar and N. Basu, “Anti-inflammatory activity of the latex of Calotropis procera,” Journal of Ethnopharmacology, vol. 44, no. 2, pp. 123–125, 1994. View at Publisher · View at Google Scholar
  15. S. Dewan, H. Sangraula, and V. L. Kumar, “Preliminary studies on the analgesic activity of latex of Calotropris procera,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 307–311, 2000. View at Publisher · View at Google Scholar
  16. S. Dewan, S. Kumar, and V. L. Kumar, “Antipyretic effect of latex of Calotropis procera,” Indian Journal of Pharmacology, vol. 32, no. 3, p. 252, 2000.
  17. S. Arya and V. L. Kumar, “Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation,” Mediators of Inflammation, vol. 2005, no. 4, pp. 228–232, 2005. View at Publisher · View at Google Scholar · View at PubMed
  18. T. Choedon, G. Mathan, S. Arya, V. L. Kumar, and V. Kumar, “Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 12, no. 16, pp. 2517–2522, 2006.
  19. Y. Wang, C. Huang, Y. Cao, and J.-S. Han, “Repeated administration of low dose ketamine for the treatment of monoarthritic pain in the rat,” Life Sciences, vol. 67, no. 3, pp. 261–267, 2000. View at Publisher · View at Google Scholar
  20. H. Sangraula, S. Dewan, and V. L. Kumar, “Evaluation of anti-inflammatory activity of latex of Calotropis procera in different models of inflammation,” Inflammopharmacology, vol. 9, no. 3, pp. 257–264, 2002. View at Publisher · View at Google Scholar
  21. V. L. Kumar, S. Roy, R. Sehgal, and B. M. Padhy, “A comparative study on the efficacy of rofecoxib in monoarticular arthritis induced by latex of Calotropis procera and Freund's complete adjuvant,” Inflammopharmacology, vol. 14, no. 1-2, pp. 17–21, 2006. View at Publisher · View at Google Scholar · View at PubMed
  22. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Publisher · View at Google Scholar
  23. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984.
  24. P. Kakkar, B. Das, and P. N. Viswanathan, “A modified spectrophotometric assay of superoxide dismutase,” Indian Journal of Biochemistry and Biophysics, vol. 21, no. 2, pp. 130–132, 1984.
  25. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967.
  26. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar
  27. D. Bilici, E. Akpinar, and A. Kiziltunç, “Protective effect of melatonin in carrageenan-induced acute local inflammation,” Pharmacological Research, vol. 46, no. 2, pp. 133–139, 2002. View at Publisher · View at Google Scholar
  28. M. C. Calixto, K. M. Trichês, and J. B. Calixto, “Analysis of the inflammatory response in the rat paw caused by the venom of Apis melifera bee,” Inflammation Research, vol. 52, no. 3, pp. 132–139, 2003. View at Publisher · View at Google Scholar
  29. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar
  30. G. D. Anderson, S. D. Hauser, K. L. McGarity, M. E. Bremer, P. C. Isakson, and S. A. Gregory, “Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis,” Journal of Clinical Investigation, vol. 97, no. 11, pp. 2672–2679, 1996.
  31. J. Keeble, M. Blades, C. Pitzalis, F. A. Castro Da Rocha, and S. D. Brain, “The role of substance P in microvascular responses in murine joint inflammation,” British Journal of Pharmacology, vol. 144, no. 8, pp. 1059–1066, 2005. View at Publisher · View at Google Scholar · View at PubMed
  32. B. Johnston, A. R. Burns, and P. Kubes, “A role for mast cells in the development of adjuvant-induced vasculitis and arthritis,” American Journal of Pathology, vol. 152, no. 2, pp. 555–563, 1998.
  33. S. Kleinau, H. Erlandsson, and L. Klareskog, “Percutaneous exposure of adjuvant oil causes arthritis in DA rats,” Clinical and Experimental Immunology, vol. 96, no. 2, pp. 281–284, 1994.
  34. F. F. Y. Lam, H. H. L. Wong, and E. S. K. Ng, “Time course and substance P effects on the vascular and morphological changes in adjuvant-induced monoarthritic rats,” International Immunopharmacology, vol. 4, no. 2, pp. 299–310, 2004. View at Publisher · View at Google Scholar · View at PubMed
  35. M. Di Rosa, J. P. Giroud, and D. A. Willoughby, “Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine,” Journal of Pathology, vol. 104, no. 1, pp. 15–29, 1971. View at Publisher · View at Google Scholar
  36. J. N. Francischi, C. T. Chaves, and A. C. L. Moura et al., “Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation,” British Journal of Pharmacology, vol. 137, no. 6, pp. 837–844, 2002. View at Publisher · View at Google Scholar · View at PubMed
  37. C.-C. Chan, S. Boyce, and C. Brideau et al., “Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach,” Journal of Pharmacology and Experimental Therapeutics, vol. 274, no. 3, pp. 1531–1537, 1995.
  38. S. C. R. Meacock and E. A. Kitchen, “Some effects of non-steroidal anti-inflammatory drugs on leucocyte migration,” Agents and Actions, vol. 6, no. 1–3, pp. 320–325, 1976. View at Publisher · View at Google Scholar
  39. J. H. Yen, J. R. Chen, W. J. Tsai, and H. W. Liu, “Correlation of tumor necrosis factor alpha levels with disease activity of rheumatoid arthritis,” Zhonghua Minguo wei sheng wu ji mian yi xue za zhi, vol. 25, no. 4, pp. 232–243, 1992.
  40. L. Philippe, P. Gegout-Pottie, and C. Guingamp et al., “Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats,” American Journal of Physiology, vol. 273, no. 4, part 2, pp. R1550–R1556, 1997.
  41. R. Kohen and A. Nyska, “Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification,” Toxicologic Pathology, vol. 30, no. 6, pp. 620–650, 2002. View at Publisher · View at Google Scholar
  42. F. Karatas, I. Ozates, H. Canatan, I. Halifeoglu, M. Karatepe, and R. Colak, “Antioxidant status & lipid peroxidation in patients with rheumatoid arthritis,” Indian Journal of Medical Research, vol. 118, pp. 178–181, 2003.
  43. A. Kamanli, M. Naziroǧlu, N. Aydilek, and C. Hacievliyagil, “Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis,” Cell Biochemistry and Function, vol. 22, no. 1, pp. 53–57, 2004. View at Publisher · View at Google Scholar · View at PubMed
  44. A. Dhir, S. S. V. Padi, P. S. Naidu, and S. K. Kulkarni, “Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice,” European Journal of Pharmacology, vol. 535, no. 1–3, pp. 192–198, 2006. View at Publisher · View at Google Scholar · View at PubMed
  45. S. Roy, R. Sehgal, B. M. Padhy, and V. L. Kumar, “Antioxidant and protective effect of latex of Calotropis procera against alloxan-induced diabetes in rats,” Journal of Ethnopharmacology, vol. 102, no. 3, pp. 470–473, 2005. View at Publisher · View at Google Scholar · View at PubMed